BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 7907025)

  • 1. Evidence for a role for central 5-HT2B as well as 5-HT2A receptors in cardiovascular regulation in anaesthetized rats.
    Knowles ID; Ramage AG
    Br J Pharmacol; 1999 Oct; 128(3):530-42. PubMed ID: 10516629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotoninergic modulation of cortical and respiratory responses to episodic hypoxia.
    Budzinska K
    Eur J Med Res; 2009 Dec; 14 Suppl 4(Suppl 4):32-7. PubMed ID: 20156721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane (DOI): From an Obscure to Pivotal Member of the DOX Family of Serotonergic Psychedelic Agents - A Review.
    Glennon RA; Dukat M
    ACS Pharmacol Transl Sci; 2024 Jun; 7(6):1722-1745. PubMed ID: 38898956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular responses produced by 5-hydroxytriptamine:a pharmacological update on the receptors/mechanisms involved and therapeutic implications.
    Villalón CM; Centurión D
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Oct; 376(1-2):45-63. PubMed ID: 17703282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The atypical 5-HT2 receptor mediating tachycardia in pithed rats: pharmacological correlation with the 5-HT2A receptor subtype.
    Centurión D; Ortiz MI; Saxena PR; Villalón CM
    Br J Pharmacol; 2002 Mar; 135(6):1531-9. PubMed ID: 11906967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular effects from stimulation of 5-hydroxytryptamine receptors.
    Saxena PR
    Fundam Clin Pharmacol; 1989; 3(3):245-65. PubMed ID: 2670724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological analysis of the cardiac effects of 5-HT and some 5-HT receptor agonists in the pithed rat.
    Dabiré H; Chaouche-Teyara K; Cherqui C; Fournier B; Schmitt H
    Fundam Clin Pharmacol; 1992; 6(6):237-45. PubMed ID: 1336759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the 5-HT1C/5-5-HT2 receptor agonists DOI and alpha-methyl-5-HT on plasma glucose and insulin levels in the rat.
    Chaouloff F; Laude D; Baudrie V
    Eur J Pharmacol; 1990 Oct; 187(3):435-43. PubMed ID: 2127400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic and regional haemodynamic effects of 1-(2,5-dimethoxy-4-iodo-phenyl)-2-aminopropane (DOI) and alpha-methyl-5-HT, in the anaesthetised rat.
    Chaouche-Teyara K; Fournier B; Safar M; Dabiré H
    Clin Exp Hypertens; 1994 Nov; 16(6):779-98. PubMed ID: 7858559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (+/-)-1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane(DOI) and alpha-methyl-5-HT: 5-HT2 receptor agonistic action on phosphatidylinositol metabolism in the rat fronto-cingulate and entorhinal cortex.
    Edwards E; Ashby CR; Wang RY
    Neuropharmacology; 1992 Jul; 31(7):615-21. PubMed ID: 1407401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central administration of 5-HT activates 5-HT1A receptors to cause sympathoexcitation and 5-HT2/5-HT1C receptors to release vasopressin in anaesthetized rats.
    Anderson IK; Martin GR; Ramage AG
    Br J Pharmacol; 1992 Dec; 107(4):1020-8. PubMed ID: 1467825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular and cardiac effects of alpha-methyl-5-HT and DOI are mediated by different 5-HT receptors in the pithed rat.
    Chaouche-Teyara K; Fournier B; Safar M; Dabiré H
    Eur J Pharmacol; 1993 Nov; 250(1):67-75. PubMed ID: 7907025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serotonin and blood pressure regulation--antihypertensive mechanism of ketanserin].
    Matsumoto M; Togashi H; Yoshioka M; Saito H
    Nihon Yakurigaku Zasshi; 1989 Oct; 94(4):207-22. PubMed ID: 2575564
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.